{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:47:35Z","timestamp":1789681655485,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005375","name":"Latvijas Zin\u0101tnes Padome","doi-asserted-by":"publisher","award":["lzp-2018\/1-0180"],"award-info":[{"award-number":["lzp-2018\/1-0180"]}],"id":[{"id":"10.13039\/501100005375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mitochondrial myopathies are a group of rare hereditary disorders that primarily affect muscle tissue, and present with muscle weakness, fatigue, exercise intolerance, and muscle pain. A key aspect of mitochondrial myopathies is the involvement of different organ systems, such as the cardiovascular system. Various disease features, including clinical and genetic heterogeneity, pose serious difficulties in the diagnostic process. We report a case of a young adult male, who presented with findings that suggested myositis, and was diagnosed with skeletal muscle myopathy and mitochondrial cardiomyopathy, caused by a m.3260A\u2009&gt;\u2009G variant in the\n                      <jats:italic>MT-TL1<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 22-year-old Latvian Caucasian man presented with a half-year history of fatigue, weakness, heaviness in the chest, and loss of breath, as well as a swollen right lower leg for about a week. Laboratory findings revealed increased creatine phosphokinase, creatinine kinase MB, and troponin T levels. All performed autoantibody tests for autoimmune disorders were negative, and no evidence of paraneoplastic syndrome was found. During repeated stays in the hospital, the patient developed heart failure and experienced decreasing muscle strength and muscle pain throughout the whole body. Following an unsuccessful therapy with corticosteroids and later L-carnitine, addition of thiamine lead to an overall improvement in the patient\u2019s condition. Based on the family history, a genetic test was performed, which revealed a m.3260A\u2009&gt;\u2009G variant in the\n                      <jats:italic>MT-TL1<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Several factors cause the process of establishing the correct diagnosis of mitochondrial myopathies and cardiomyopathies to be challenging. The presented case aims to raise awareness of rare mitochondrial myopathies, to help clinicians speed up the diagnostic process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05633-0","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:59:29Z","timestamp":1762444769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitochondrial cardiomyopathy with skeletal muscle myopathy caused by m.3260A\u2009&gt;\u2009G mutation in MT-TL1 gene: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Anda","family":"Kadi\u0161a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritvars","family":"Vereskuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihails","family":"Tarasovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Mi\u010dule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Inashkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"5633_CR1","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1111\/ene.15854","volume":"30","author":"D Menon","year":"2023","unstructured":"Menon D, Alnajjar S, Katzberg H, Barnett C, Bril V. Demographic and clinical determinants of the quality of life in adults with inherited and acquired myopathies. Eur J Neurol. 2023;30:2518\u201324.","journal-title":"Eur J Neurol"},{"key":"5633_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.nmd.2017.08.006","volume":"27","author":"M Mancuso","year":"2017","unstructured":"Mancuso M, McFarland R, Klopstock T, Hirano M, Artuch R, Bertini E, et\u00a0al. International workshop: outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations.16\u201318 November 2016, Rome, Italy. Neuromuscul Disord. 2017;27:1126\u201337.","journal-title":"Neuromuscul Disord"},{"key":"5633_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, et\u00a0al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77:753\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"5633_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0971-5916.154489","volume":"141","author":"NA Khan","year":"2015","unstructured":"Khan NA, Govindaraj P, Meena AK, Thangaraj K. Mitochondrial disorders: challenges in diagnosis and treatment. Indian J Med Res. 2015;141(1):13\u201326.","journal-title":"Indian J Med Res"},{"key":"5633_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11910-010-0096-4","volume":"10","author":"A Berardo","year":"2010","unstructured":"Berardo A, DiMauro S, Hirano M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep. 2010;10:118\u201326.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"5633_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.recesp.2014.09.006","volume":"68","author":"M Gallego-Delgado","year":"2015","unstructured":"Gallego-Delgado M, Cobo-Marcos M, Bornstein B, Hern\u00e1ndez-La\u00edn A, Alonso-Pulp\u00f3n L, Garcia-Pavia P. Mitochondrial cardiomyopathies associated with the m.3243A>G mutation in the MT-TL1 gene: two sides of the same coin. Rev Esp Cardiol. 2015;68(2):153\u20135.","journal-title":"Rev Esp Cardiol"},{"key":"5633_CR7","first-page":"221","volume":"35","author":"G St-Pierre","year":"2019","unstructured":"St-Pierre G, Steinberg C, Dubois M, Senechal M. What the cardiologist should know about mitochondrial cardiomyopathy? Can J Cardiol. 2019;35:221\u20134.","journal-title":"Can J Cardiol"},{"issue":"7","key":"5633_CR8","first-page":"1115","volume":"29","author":"D Pelnena","year":"2018","unstructured":"Pelnena D, Burnyte B, Jankevics E, Lace B, Dagyte B, Grigalioniene K, et\u00a0al. Complete mtDNA sequencing reveals mutations m.9185T>C and m.13513G>A in three patients with Leigh syndrome. Mitochondrial DNA A DNA Mapp Seq Anal. 2018;29(7):1115\u201320.","journal-title":"Mitochondrial DNA A DNA Mapp Seq Anal"},{"key":"5633_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2007.00836.x","volume":"116","author":"J Finsterer","year":"2007","unstructured":"Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand. 2007;116:1\u201314.","journal-title":"Acta Neurol Scand"},{"key":"5633_CR10","first-page":"183","volume":"53","author":"A Mattman","year":"2011","unstructured":"Mattman A, Sirrs S, Mezei MM, Salvarinova-Zivkovic R, Alfadhel M, Lillquist Y. Mitochondrial disease clinical manifestations: an overview. BCMJ. 2011;53:183\u20137.","journal-title":"BCMJ"},{"key":"5633_CR11","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41433-023-02523-x","volume":"37","author":"BS Chen","year":"2023","unstructured":"Chen BS, Harvey JP, Gilhooley MJ, Jurkute N, Yu-Wai-Man P. Mitochondria and the eye\u2014manifestations of mitochondrial diseases and their management. Eye. 2023;37:2416\u201325.","journal-title":"Eye"},{"issue":"4","key":"5633_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/js.2017-00434","volume":"2","author":"IS Al-Gadi","year":"2018","unstructured":"Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine disorders in primary mitochondrial disease. J Endocr Soc. 2018;2(4):361\u201373.","journal-title":"J Endocr Soc"},{"issue":"3","key":"5633_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.clineuro.2004.07.001","volume":"107","author":"J Finsterer","year":"2005","unstructured":"Finsterer J. Mitochondrial neuropathy. Clin Neurol Neurosurg. 2005;107(3):181\u20136.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"5633_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/1756283X16666806","volume":"10","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Frank M. Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Ther Adv Gastroenterol. 2017;10(1):142\u201354.","journal-title":"Ther Adv Gastroenterol"},{"issue":"Pt 2","key":"5633_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/brain\/awg028","volume":"126","author":"T Taivassalo","year":"2003","unstructured":"Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, Haller RG. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126(Pt 2):413\u201323.","journal-title":"Brain"},{"issue":"4","key":"5633_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","volume":"15","author":"ST Ahmed","year":"2018","unstructured":"Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE. Diagnosis and treatment of mitochondrial myopathies. Neurotherapeutics. 2018;15(4):943\u201353.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"5633_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/eurjhf\/hfp186","volume":"12","author":"G Limongelli","year":"2010","unstructured":"Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail. 2010;12(2):114\u201321.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"5633_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nmd.2015.03.001","volume":"25","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Elson JL, Newman J, Payne B, MacFarland R, Newton LJ, Turnbull DM. Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul Disord. 2015;25(7):563\u20136.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"5633_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7861\/clinmedicine.13-1-87","volume":"13","author":"MJ Keogh","year":"2013","unstructured":"Keogh MJ, Chinnery PF. How to spot mitochondrial disease in adults. Clin Med. 2013;13(1):87\u201392.","journal-title":"Clin Med"},{"issue":"2","key":"5633_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10048-019-00601-5","volume":"21","author":"C Ticci","year":"2020","unstructured":"Ticci C, Sicca F, Ardissone A, Bertini E, Carelli V, Diodato F, et\u00a0al. Mitochondrial epilepsy: a cross-sectional nationwide Italian survey. Neurogenetics. 2020;21(2):87\u201396.","journal-title":"Neurogenetics"},{"issue":"24","key":"5633_CR21","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","volume":"33","author":"MG Bates","year":"2012","unstructured":"Bates MG, Bourke JP, Giordano C, d\u2019Amati G, Turnbull DM, Taylor RW. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J. 2012;33(24):3023\u201333.","journal-title":"Eur Heart J"},{"issue":"2","key":"5633_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000402","volume":"6","author":"E Barca","year":"2020","unstructured":"Barca E, Long Y, Cooley V, Schoenaker R, Emmanuele V, DiMauro S, et\u00a0al. Mitochondrial diseases in North America: an analysis of the NAMDC registry. Neurol Genet. 2020;6(2): e402.","journal-title":"Neurol Genet"},{"key":"5633_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.107","author":"S Parikh","year":"2017","unstructured":"Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et\u00a0al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017. https:\/\/doi.org\/10.1038\/gim.2017.107.","journal-title":"Genet Med"},{"issue":"Pt 2","key":"5633_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/brain\/118.2.339","volume":"118","author":"MJ Jackson","year":"1995","unstructured":"Jackson MJ, Schaefer JA, Johnson MA, Morris AA, Turnbull DM, Bindoff LA. Presentation, and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain. 1995;118(Pt 2):339\u201357.","journal-title":"Brain"},{"key":"5633_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/practneurol-2019-002465","volume":"20","author":"J Walters","year":"2020","unstructured":"Walters J, Baborie A. Muscle biopsy: what and why and when? Pract Neurol. 2020;20:385\u201395.","journal-title":"Pract Neurol"},{"issue":"4","key":"5633_CR26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1542\/peds.2004-0718","volume":"114","author":"F Scaglia","year":"2004","unstructured":"Scaglia F, Towbin JA, Craigen WJ, Belmont JW, O\u2019Brian Smith E, Neish SR, et\u00a0al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114(4):925\u201331.","journal-title":"Pediatrics"},{"issue":"11","key":"5633_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115742","volume":"22","author":"C Mazzaccara","year":"2021","unstructured":"Mazzaccara C, Mirra B, Barretta F, Caiazza M, Lombardo B, Scudiero O, et\u00a0al. Molecular epidemiology of mitochondrial cardiomyopathy: a search among mitochondrial and nuclear genes. Int J Mol Sci. 2021;22(11): 5742.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5633_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pcl.2016.08.011","volume":"64","author":"DP Dimmock","year":"2017","unstructured":"Dimmock DP, Lawlor MW. Presentation and diagnostic evaluation of mitochondrial disease. Pediatr Clin North Am. 2017;64(1):161\u201371.","journal-title":"Pediatr Clin North Am"},{"key":"5633_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2019.01.017","volume":"279","author":"A Imai-Okazaki","year":"2019","unstructured":"Imai-Okazaki A, Kishita Y, Kohda M, et\u00a0al. Cardiomyopathy in children with mitochondrial disease: prognosis and genetic background. Int J Cardiol. 2019;279:115\u201321.","journal-title":"Int J Cardiol"},{"issue":"5","key":"5633_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35072063","volume":"2","author":"J Smeitink","year":"2001","unstructured":"Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet. 2001;2(5):342\u201352.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"5633_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","volume":"83","author":"HR Elliott","year":"2008","unstructured":"Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet. 2008;83(2):254\u201360.","journal-title":"Am J Hum Genet"},{"issue":"8760","key":"5633_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0140-6736(91)90136-D","volume":"338","author":"M Zeviani","year":"1991","unstructured":"Zeviani M, Gellera C, Antozzi C, Rimoldi D, Morandi L, Villani F, et\u00a0al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet. 1991;338(8760):143\u20137.","journal-title":"Lancet"},{"issue":"3","key":"5633_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1172\/JCI117061","volume":"93","author":"C Mariotti","year":"1994","unstructured":"Mariotti C, Tiranti V, Carrara F, Dallapiccola B, DiDonato S, Zeviani M. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy. J Clin Invest. 1994;93(3):1102\u20137.","journal-title":"J Clin Invest"},{"issue":"12","key":"5633_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S","volume":"19","author":"I Nishino","year":"1996","unstructured":"Nishino I, Komatsu M, Kodama S, Horai S, Nonaka I, Goto Y. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Muscle Nerve. 1996;19(12):1603\u20134.","journal-title":"Muscle Nerve"},{"key":"5633_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2021.06.042","volume":"341","author":"A Imai-Okazaki","year":"2021","unstructured":"Imai-Okazaki A, Matsunaga A, Yatsuka Y, Nitta KR, Kishita Y, Suigura A, et\u00a0al. Long-term prognosis and genetic background of cardiomyopathy in 223 pediatric mitochondrial disease patients. Int J Cardiol. 2021;341:48\u201355.","journal-title":"Int J Cardiol"},{"issue":"2","key":"5633_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2010.10.060","volume":"402","author":"BS Connolly","year":"2010","unstructured":"Connolly BS, Feigenbaum AS, Robinson BH, Dipchand AI, Simon DK, Tarnopolsky MA. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochem Biophys Res Commun. 2010;402(2):443\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6158","key":"5633_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/331717a0","volume":"331","author":"IJ Holt","year":"1988","unstructured":"Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331(6158):717\u20139.","journal-title":"Nature"},{"issue":"5","key":"5633_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/BF01800024","volume":"15","author":"S Miyabayashi","year":"1992","unstructured":"Miyabayashi S, Hanamizu H, Nakamura R, Endo H, Tada K. Defects of mitochondrial respiratory enzymes in cloned cells from MELAS fibroblasts. J Inherit Metab Dis. 1992;15(5):797\u2013802.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"5633_CR39","first-page":"852","volume":"50","author":"Y Tatuch","year":"1992","unstructured":"Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JT, Wherret J, Smith C, et\u00a0al. Heteroplasmic mtDNA mutation (T\u2013\u2013G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992;50(4):852\u20138.","journal-title":"Am J Hum Genet"},{"key":"5633_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11940-009-0046-0","volume":"11","author":"S Parikh","year":"2009","unstructured":"Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, et\u00a0al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol. 2009;11:414\u201330.","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"5633_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.09.009","volume":"122","author":"AW El-Hattab","year":"2017","unstructured":"El-Hattab AW, Zarante AM, Almannai M, Scaglia F. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab. 2017;122(3):1\u20139.","journal-title":"Mol Genet Metab"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05633-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:59:30Z","timestamp":1762444770000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5633"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05633-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved the Central Committee of Medical Ethics of Latvia (protocol No.2016\u20135, chapter 2, approved 24 November 2016). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"573"}}